The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

Market Size and Growth Rates

• The clinical nutrition for cancer care market has seen significant growth, expanding from $4.67 billion in 2023 to $4.92 billion in 2024, reflecting a CAGR of 5.5%.
• This growth is set to continue, with projections showing the market reaching $6.14 billion by 2028 at a CAGR of 5.7%.

Key Drivers of Growth

• Raising Awareness: Increased understanding of nutritional needs among cancer patients has boosted market growth.
• Precision Nutrition: The emergence of personalized nutrition approaches tailored to individual needs.
• Healthcare Policy Changes: Improved healthcare policies and reimbursement models have facilitated greater access to nutritional support.
• Surgical Interventions: Nutritional support is becoming crucial for patients undergoing cancer surgeries.
• Functional Foods and Supplements: There is growing interest in functional foods, nutraceuticals, and dietary supplements to aid in cancer care.

View More On The Clinical Nutrition For Cancer Care Market Report 2024 – https://www.thebusinessresearchcompany.com/report/clinical-nutrition-for-cancer-care-global-market-report

Future Growth Prospects

• Personalized Medicine: A shift towards personalized medicine and precision nutrition approaches is expected to drive future market growth.
• Clinical Nutrition Demand: Rising demand for clinical nutrition interventions to support cancer patients.
• Impact Awareness: Increasing awareness of how nutrition impacts cancer treatment outcomes.
• Technological Advancements: Innovations in cancer treatment are integrating structured clinical nutrition pathways in oncology.

Major Trends Shaping the Market

• Nutritional Biomarker Research: Advances in identifying biomarkers to tailor nutritional interventions.
• Technological Innovations: New nutritional products and delivery systems are enhancing patient care.
• Oncologist Collaboration: Increased collaboration between oncologists and nutritionists to optimize patient outcomes.
• Nutritional Science Advancements: Ongoing research and development in nutritional science continue to improve clinical nutrition products.

Rising Cancer Prevalence

• Cancer Cases: The increasing prevalence of cancer is a significant driver of the clinical nutrition market. With life expectancy rising, more aging individuals are becoming susceptible to cancer.
• Projected Growth: According to the World Health Organization, new cancer cases are expected to reach approximately 35 million by 2050, a 77% increase from 2022.
• Nutritional Support: Clinical nutrition is crucial for providing specialized dietary management and nutritional support tailored to cancer patients.

Key Players in the Market

• Major Companies: Pfizer Inc., Bayer AG, Abbott Nutrition, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Evonik Industries AG, Baxter International Inc., Otsuka Holdings Co. Ltd., B. Braun Melsungen AG, Koninklijke DSM N.V., Glanbia plc, Kyowa Kirin Co. Ltd., Nestle Health Science S.A., Danone Nutricia, BioGaia AB, Meiji Holdings Company Ltd., Hormel Health Labs, Victus Inc., Taiho Pharmaceutical Co. Ltd., Global Health Products Inc.

Innovative Clinical Nutrition Products

• Oral Nutritional Supplements: Companies are developing advanced products like oral nutritional supplements to provide targeted support for cancer patients.
• Nestle’s Launch: In July 2022, Nestle launched Oral Impact Su Yi Su in China, a supplement formulated with arginine and fish omega-3 to support tumor-related conditions.

Strategic Partnerships

• Danone and Resilience: In January 2024, Danone partnered with Resilience to create a nutrition and oncology module within Resilience’s digital oncology solution, addressing cancer-related malnutrition affecting up to 70% of cancer patients.

Market Segmentation

• By Type: Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas.
• By Cancer Type: Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Blood Cancer, Breast Cancer, Lung Cancer, Other Cancer Types.
• By Age Group: Adult, Pediatric.
• By Sales Channel: Online, Retail, Institutional Sales.

Regional Insights

• North America: The largest region in the clinical nutrition for cancer care market in 2023, reflecting advanced healthcare infrastructure and high awareness levels.

In conclusion, the clinical nutrition for cancer care market is poised for robust growth, driven by rising cancer prevalence, advancements in nutritional science, and the increasing integration of personalized and precision nutrition approaches in oncology care.

Request A Sample Of The Global Clinical Nutrition For Cancer Care Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16017&type=smp